Technical notes using the Echo® MS+ system

Jun 17, 2025 | Blogs, Echo® MS+ system, Pharma | 0 comments

The Echo® MS+ system comprises of an open-port interface (OPI) and acoustic droplet ejection (ADE) module which could be coupled with a mass spectrometer. The mass spectrometer could either be a SCIEX Triple Quad 6500+ system or the ZenoTOF 7600 system. This non-liquid chromatography based; high-throughput screening platform enables rapid analysis of compounds at speeds of up to 1 sample/second.

Download the technical notes below to learn more about this game-changing technology and the applications that can be conducted using the Echo® MS+ system.

Rapid MS/MS analysis with Acoustic Ejection Mass Spectrometry (AEMS). SCIEX technical note, RUO-MKT-02-11385-A
True high throughput bioanalysis using the Echo® MS System. SCIEX technical note, RUO-MKT-02-11649-A
Rapid quantitative analysis of fermentation broth samples to assess efficiency of engineered yeast strain turnover. SCIEX technical note, RUO-MKT-02-11695-A
Accelerating synthetic biology with very fast screening of metabolites in fermentation broth. SCIEX technical note, RUO-MKT-02-14011-A
Accelerated pharmacokinetic profiling and metabolite monitoring Using Echo® MS System. SCIEX technical note, RUO-MKT-02-12894-A
True high-throughput analysis of transporter activity screens. SCIEX technical note, RUO-MKT-02-13968-A
Ultra-fast quantification of alprazolam in human plasma extracts. SCIEX technical note, RUO-MKT-02-13059-A
High-throughput metabolite quantification for synthetic biology. SCIEX technical note, RUO-MKT-02-13362-A
Ultra-fast, accurate and simultaneous quantification of ritonavir and lopinavir in human plasma. SCIEX technical note, RUO-MKT-02-13058-A
Accelerating turnaround time in high-throughput ADME pipelines. SCIEX technical note, RUO-MKT-02-14235-B
Automating high-throughput ADME assays with LeadScape® 3.0 Analyze software on the Echo® MS system. SCIEX technical note, RUO-MKT-02-14841-A
Optimizing robustness for high-throughput screening on the Echo® MS+ system. SCIEX technical note, MKT- 31348-A
High-speed compound quality assessment using Acoustic Ejection Mass Spectrometry. SCIEX technical note, MKT-31143-A
High-throughput protein analysis using acoustic ejection mass spectrometry. SCIEX technical note, MKT- 31206-A
An automated, real-time measurement of kinetic hydrolysis of glucuronide using the Echo® MS+ system with ZenoTOF 7600 system. SCIEX technical note, MKT-31227-A
Automated, rapid method optimization and buffer screening using the Echo® MS+ system with ZenoTOF 7600 system. SCIEX technical note, MKT-30777-1
Determining optimal buffer concentration and compatibility for high-throughput intact protein analysis. SCIEX technical note, MKT-30944-A
High-resolution, specific analysis of arginine and citrulline on the Echo® MS+ system with ZenoTOF 7600 system. SCIEX technical note, MKT-27824-A
Rapid insulin analysis before-and-after TCEP reduction using the Echo® MS+ system with ZenoTOF 7600 system. SCIEX technical note, MKT-27824-A
Rapid and accurate quantitation of thyroglobulin biomarkers using the Echo® MS+ system with ZenoTOF 7600 system. SCIEX technical note, MKT-27824-A

Why electron-activated dissociation (EAD) improves sequence variant analysis in biopharma LC/MS workflows

In biopharmaceutical development, sequence variants (SV) are considered an inherent risk of producing complex proteins in living systems. Sequence variants are unintended changes to the amino acid sequence of a biotherapeutic and can be caused by errors in transcription or translation in the host cell, or cell culture and process conditions. Detailed analysis of SVs is important in process and product development to ensure the drug’s safety and efficacy. Even low‑level sequence variants can have significant implications for product quality, safety, and efficacy, making their accurate detection and characterization a critical requirement across development, process optimization, and regulatory submission.

How NFD improves impurity detection and peak integration in CE SDS workflows

CE‑SDS remains a cornerstone assay for characterizing fragmentation, aggregation, and product‑related impurities in therapeutic proteins. UV detection has been the long‑standing standard. However, it frequently struggles with baseline noise, limited sensitivity for minor fragments, and subjective integration.

What´s new in SCIEX Now – spring release 2026

At SCIEX, innovation doesn’t stop at instruments; it extends to how you interact with your LC-MS/MS or CE systems every day. That’s why we’re excited to introduce the SCIEX Now spring 2026 improvements: a set of meaningful enhancements shaped directly by your feedback.

Posted by

Anuja Bhalkikar

Anuja Bhalkikar is a Senior Scientist at SCIEX’s Echo® MS Center of Excellence. She supports the Echo® MS+ product line and is responsible for conducting customer demonstrations, providing technical support to clients that includes streamlining automation along with the EchoMS+ system, and generating new workflows. Anuja earned her Ph.D. in Chemistry from the University of Nebraska-Lincoln. She worked in a precision oncology clinical testing laboratory and the bioanalysis division at PPD a part of Thermo Fisher Scientific before joining SCIEX.

0 Comments